To treat rare disease, NIH scientists repurpose FDA-approved drug
A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known ...
Sep 2, 2011
0
0